Gene-based passive antibody protection from HIV

Nature Biotechnology

Volumn 30, Issue 2, 2012, Pages 156-157

  Liu, Margaret A ^a,b,c  

^a International Vaccine Institute   (South Korea)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ProTherImmune   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CD4+ T LYMPHOCYTE; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HIV; HIV INFECTIONS; HUMANS; MICE;

EID: 84856727273     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2114     Document Type: Short Survey

References (11)

1. Balazs, A.B. et al. Nature 481, 81-84 (2012).
2. Kwong, P.D. & Wilson, I.A. Nat. Immunol. 10, 573-578 (2009).
3. Fang, J. et al. Nat. Biotechnol. 23, 584-590 (2005).
4. Wang, G. et al. Cancer Gene Ther. 17, 559-570 (2010).
5. Ganor, Y. & Bomsel, M. Am. J. Reprod. Immunol. 65, 284-291 (2011).
6. Venkatachari, N.J., Alber, S., Watkins, S.C. & Ayyavoo, V. PLoS ONE 4, e7470 (2009).
7. Nathwani, A.C. et al. N. Engl. J. Med. 365, 2357-2365 (2011).
8. Rogers, G.L. et al. Front. Microbiol. 2, 194 (2011).
9. Murphy, S.L. et al. J. Med. Virol. 81, 65-74 (2009).
10. Wang, Z. et al. Mol. Ther. 18, 617-624 (2010).
11. Favaro, P. et al. Mol. Ther. 17, 1022-1030 (2009).